loading
Precedente Chiudi:
$3.34
Aprire:
$3.33
Volume 24 ore:
1.75M
Relative Volume:
1.11
Capitalizzazione di mercato:
$546.81M
Reddito:
$400.57M
Utile/perdita netta:
$9.21M
Rapporto P/E:
-0.5695
EPS:
-6.04
Flusso di cassa netto:
$146.36M
1 W Prestazione:
-18.29%
1M Prestazione:
-15.69%
6M Prestazione:
-47.00%
1 anno Prestazione:
-63.75%
Intervallo 1D:
Value
$3.26
$3.50
Intervallo di 1 settimana:
Value
$3.26
$4.20
Portata 52W:
Value
$3.26
$15.70

Ironwood Pharmaceuticals Inc Stock (IRWD) Company Profile

Name
Nome
Ironwood Pharmaceuticals Inc
Name
Telefono
617-621-7722
Name
Indirizzo
100 SUMMER STREET, SUITE 2300, BOSTON, MA
Name
Dipendente
267
Name
Cinguettio
@ironwoodpharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
IRWD's Discussions on Twitter

Confronta IRWD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
IRWD 3.44 546.81M 400.57M 9.21M 146.36M -6.04
ZTS 176.96 79.84B 9.15B 2.43B 2.31B 4.92
HLN 9.65 43.63B 14.26B 1.55B 0 0.3327
TAK 13.38 42.42B 30.27B 1.93B 3.45B 0.444
TEVA 17.12 19.40B 16.77B -959.00M 1.37B -2.00
VTRS 13.37 15.96B 15.05B -883.30M 1.89B 1.53

Ironwood Pharmaceuticals Inc Stock (IRWD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-01-17 Iniziato Craig Hallum Buy
2023-12-14 Iniziato Wells Fargo Overweight
2023-11-09 Iniziato Jefferies Buy
2023-09-28 Iniziato JMP Securities Mkt Outperform
2022-09-02 Iniziato CapitalOne Overweight
2022-04-22 Iniziato Piper Sandler Overweight
2020-09-30 Downgrade Wells Fargo Overweight → Equal Weight
2020-06-17 Iniziato Northland Capital Outperform
2019-07-10 Ripresa Credit Suisse Neutral
2019-03-27 Aggiornamento Morgan Stanley Underweight → Equal-Weight
2019-02-25 Aggiornamento H.C. Wainwright Sell → Neutral
2019-01-24 Aggiornamento JP Morgan Underweight → Neutral
2018-11-07 Downgrade Credit Suisse Outperform → Neutral
2018-11-07 Downgrade JP Morgan Neutral → Underweight
2018-07-23 Iniziato H.C. Wainwright Sell
2018-05-09 Downgrade Morgan Stanley Equal-Weight → Underweight
2018-01-05 Downgrade BofA/Merrill Buy → Underperform
2017-12-06 Downgrade Mizuho Buy → Neutral
2017-07-21 Downgrade JP Morgan Overweight → Neutral
2017-05-03 Iniziato Wells Fargo Outperform
2017-04-07 Reiterato Mizuho Buy
2017-02-22 Reiterato Barclays Equal Weight
2016-11-04 Reiterato Mizuho Buy
2016-10-24 Reiterato Wedbush Neutral
2016-10-10 Reiterato Mizuho Buy
2016-09-27 Reiterato WallachBeth Hold
Mostra tutto

Ironwood Pharmaceuticals Inc Borsa (IRWD) Ultime notizie

pulisher
04:30 AM

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Acquired by KBC Group NV - Defense World

04:30 AM
pulisher
Nov 23, 2024

Principal Financial Group Inc. Has $3.03 Million Stake in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 23, 2024
pulisher
Nov 22, 2024

Pacer Advisors Inc. Grows Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 22, 2024
pulisher
Nov 21, 2024

IRWDIronwood Pharmaceuticals, Inc.Latest Stock News & Market Updates - StockTitan

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 - Investing.com India

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Stake Lessened by Sumitomo Mitsui Trust Group Inc. - Defense World

Nov 21, 2024
pulisher
Nov 21, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 By Investing.com - Investing.com South Africa

Nov 21, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares worth $21,868 - Investing.com

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals SVP sells shares for $44,884 By Investing.com - Investing.com Canada

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Stock Declines Despite Industry Gains - GuruFocus.com

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood's Q3 Earnings Lag Estimates, Revenues Top, Stock Down - MSN

Nov 20, 2024
pulisher
Nov 20, 2024

Ironwood Pharmaceuticals (IRWD) Misses Q3 Earnings Estimates - MSN

Nov 20, 2024
pulisher
Nov 16, 2024

Ironwood Pharmaceuticals, Inc. Announces Resignation of Andrew Davis as Senior Vice President and Chief Business Officer, Effective November 22, 2024 - Marketscreener.com

Nov 16, 2024
pulisher
Nov 15, 2024

ARMISTICE CAPITAL, LLC Acquires Significant Stake in Ironwood Ph - GuruFocus.com

Nov 15, 2024
pulisher
Nov 15, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $10.40 Consensus PT from Analysts - Defense World

Nov 15, 2024
pulisher
Nov 14, 2024

GSA Capital Partners LLP Purchases 232,087 Shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 14, 2024
pulisher
Nov 13, 2024

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference - Business Wire

Nov 13, 2024
pulisher
Nov 13, 2024

Ironwood Pharmaceuticals executive resigns - Investing.com India

Nov 13, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals executive resigns By Investing.com - Investing.com UK

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results and Recent Business Performance - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Lowered to “Buy” Rating by StockNews.com - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Creative Planning Increases Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - Defense World

Nov 12, 2024
pulisher
Nov 12, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Cut to Buy at StockNews.com - MarketBeat

Nov 12, 2024
pulisher
Nov 11, 2024

What is Leerink Partnrs’ Estimate for IRWD FY2024 Earnings? - Defense World

Nov 11, 2024
pulisher
Nov 11, 2024

FY2024 Earnings Forecast for IRWD Issued By Leerink Partnrs - MarketBeat

Nov 11, 2024
pulisher
Nov 10, 2024

Robeco Institutional Asset Management B.V. Raises Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 10, 2024
pulisher
Nov 09, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results - MarketBeat

Nov 09, 2024
pulisher
Nov 09, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 09, 2024
pulisher
Nov 08, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highli - GuruFocus.com

Nov 08, 2024
pulisher
Nov 08, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... - Yahoo Finance

Nov 08, 2024
pulisher
Nov 07, 2024

Earnings call: Ironwood Pharmaceuticals reports robust LINZESS demand By Investing.com - Investing.com Canada

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood: Q3 Earnings Snapshot - Houston Chronicle

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Shares Gap DownTime to Sell? - MarketBeat

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Q3 Earnings: Revenue Beats at $91.59M, EPS Misses at $0.02 - GuruFocus.com

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results - Business Wire

Nov 07, 2024
pulisher
Nov 07, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Call Highlights: Navigating Growth Amidst ... By GuruFocus - Investing.com Canada

Nov 07, 2024
pulisher
Nov 06, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Prev - GuruFocus.com

Nov 06, 2024
pulisher
Nov 06, 2024

Ironwood Pharmaceuticals Inc (IRWD) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance

Nov 06, 2024
pulisher
Nov 06, 2024

StockNews.com Upgrades Ironwood Pharmaceuticals (NASDAQ:IRWD) to Strong-Buy - Defense World

Nov 06, 2024
pulisher
Nov 05, 2024

Ironwood Pharmaceuticals (IRWD) Sees Stock Surge Amid Positive A - GuruFocus.com

Nov 05, 2024
pulisher
Nov 05, 2024

Ironwood Pharmaceuticals Announces Agreement with Teva Involving LINZESS® (linaclotide) 72 mcg Dosage Strength - Marketscreener.com

Nov 05, 2024
pulisher
Nov 05, 2024

Vanguard Group Inc's Strategic Acquisition in Ironwood Pharmaceu - GuruFocus.com

Nov 05, 2024
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Upgraded at StockNews.com - MarketBeat

Nov 04, 2024
pulisher
Nov 04, 2024

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Allspring Global Investments Holdings LLC - Defense World

Nov 04, 2024
pulisher
Nov 04, 2024

Emerald Advisers LLC Has $1.88 Million Stock Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) - MarketBeat

Nov 04, 2024
pulisher
Oct 31, 2024

Where Are They Now? Ironwood Pharmaceuticals - Life Science Leader Magazine

Oct 31, 2024
pulisher
Oct 31, 2024

Ironwood Pharmaceuticals (IRWD) Scheduled to Post Earnings on Thursday - MarketBeat

Oct 31, 2024
pulisher
Oct 29, 2024

What Do Analysts Think About Ironwood Pharmaceuticals Inc’s (NASDAQ:IRWD) Future? - Stocks Register

Oct 29, 2024
pulisher
Oct 28, 2024

Short Bowel Syndrome Market to Show Remarkable Growth Trends - openPR

Oct 28, 2024
pulisher
Oct 28, 2024

Ironwood Pharmaceuticals (NASDAQ:IRWD) Trading 9.1% HigherHere's What Happened - MarketBeat

Oct 28, 2024

Ironwood Pharmaceuticals Inc Azioni (IRWD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Ironwood Pharmaceuticals Inc Azioni (IRWD) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Emany Sravan Kumar
SVP, COO and CFO
Nov 18 '24
Sale
4.08
11,001
44,884
309,572
$90.52
price up icon 3.66%
$13.36
price down icon 0.30%
$85.69
price up icon 0.28%
$60.98
price up icon 2.21%
$125.65
price up icon 0.52%
$13.37
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):